The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)

Overview of attention for article published in Journal for Immunotherapy of Cancer, July 2019

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#42 of 3,061)
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news: 15 news outlets
twitter: 61 tweeters

facebook: 1 Facebook page

Citations

dimensions_citation: 332 Dimensions

Readers on

mendeley: 283 Mendeley

Summary News Twitter Facebook Dimensions citations

So far, Altmetric has seen 93 tweets from 61 users, with an upper bound of 279,449 followers.

Looking forward to seeing mature data on immunotherapy in the noeadjuvant and adjuvant settings at #ASCO21, including a presentation from #SITCGuidelines HNSCC expert panel member Dr. Ravi Uppaluri @DrUppaluri. Read the original CPG in JITC https://t.co/ND

07 Jun 2021

Reply Retweet Favourite

New2Trip: Society for Immunotherapy of Cancer consensus statement on immunotherapy for treatment of squamous cell carcinoma of head & neck (HNSCC) https://t.co/4N7recdY0T

19 Jan 2020

Reply Retweet Favourite

New2Trip: Society for Immunotherapy of Cancer consensus statement on immunotherapy for treatment of squamous cell carcinoma of head & neck (HNSCC) https://t.co/4N7recdY0T

16 Jan 2020

Reply Retweet Favourite

New2Trip: Society for Immunotherapy of Cancer consensus statement on immunotherapy for treatment of squamous cell carcinoma of head & neck (HNSCC) https://t.co/QG5x1vOEbQ

16 Jan 2020

Reply Retweet Favourite

This page shows the most recent tweets that mention this research output.

Click here to find out how to access more activity, including 89 additional tweets.